As such, genetic testing for SPG7 remains an important consideration in the work-up of spastic paraplegia, cerebellar signs or ataxia, and other neuro-ophthalmologic manifestations, including optic atrophy, cerebellar eye signs, and PEO. This evidence concerns the gene SPG7 and optic atrophy.